M&A Deal Summary |
|
---|---|
Date | 2023-08-31 |
Target | Acer |
Sector | Life Science |
Buyer(s) | Zevra Therapeutics |
Deal Type | Merger |
Deal Value | 91M USD |
Advisor(s) | William Blair (Financial) Pillsbury Winthrop Shaw Pittman LLP (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Sector | Life Science |
Revenue | 10M USD (2022) |
Zevra Therapeutics is a rare disease company melding science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. Zevra Therapeutics is based in Celebration, Florida.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Merger) | 1 of 1 |
State (Massachusetts) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2023) | 1 of 1 |
Size (of disclosed) | 1 of 1 |